{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T13:31:15Z","timestamp":1751549475410},"reference-count":14,"publisher":"Tohoku University Medical Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2006]]},"DOI":"10.1620\/tjem.208.355","type":"journal-article","created":{"date-parts":[[2006,3,24]],"date-time":"2006-03-24T05:59:05Z","timestamp":1143179945000},"page":"355-359","source":"Crossref","is-referenced-by-count":3,"title":["Effective Treatment with Cyclosporine A of a Child with Systemic Lupus Erythematosus Resistant to Cyclophosphamide Pulse Therapy"],"prefix":"10.1620","volume":"208","author":[{"given":"Koichi","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Hirosaki University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hirosaki University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Tsugawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hirosaki University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eturo","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hirosaki University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Balow, J.E. &amp; Austin, H.A. (2004) Treatment of proliferative lupus nephritis. <i>Am. J. Kidney Dis<\/i>., <b>43<\/b>, 383-385.","DOI":"10.1053\/j.ajkd.2003.12.008"},{"key":"2","doi-asserted-by":"publisher","unstructured":"Boletis, J., Ioannidis, J. &amp; Boki, K. (1999) Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis. <i>Lancet<\/i>, <b>354<\/b>, 569-570.","DOI":"10.1016\/S0140-6736(99)01575-5"},{"key":"3","doi-asserted-by":"publisher","unstructured":"Boumpas, D.T., Austin, H.A., Vaughn, E.M., Klippel, J.H., Steinberg, A.D., Yarboro, C.H. &amp; Balow, J.E. (1992) Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. <i>Lancet<\/i>, <b>340<\/b>, 741-745.","DOI":"10.1016\/0140-6736(92)92292-N"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Caccavo, D., Lagana, B., Mitterhofer, A.P., Ferri, G.M., Afeltra, A., Amoroso, A. &amp; Bonomo, L. (1997) Long-term treatment of systemic lupus erythematosus with cyclosporine A. <i>Arthritis Rheum<\/i>., <b>40<\/b>, 27-35.","DOI":"10.1002\/art.1780400106"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Ferrario, L., Bellone, M., Bozzolo, E., Baldissera, E. &amp; Sabbadini, M.D. (1999) Remission from lupus nephritis resistant to cyclophosphamide after additional treatment with cyclosporine A. <i>Rheumatol<\/i>., <b>39<\/b>, 218-220.","DOI":"10.1093\/rheumatology\/39.2.218A"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Gourley, M.F., Austin, H.A., III., Scott, D., Yarboro, C.H., Vaughan E.M., Muir, J., Boumpas, D.T., Klippel, J.H., Balow, J.E. &amp; Steinberg, A.D. (1996) Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomised, controlled trial. <i>Ann. Intern. Med<\/i>., <b>125<\/b>, 549-557.","DOI":"10.7326\/0003-4819-125-7-199610010-00003"},{"key":"7","doi-asserted-by":"publisher","unstructured":"Griffiths, B. &amp; Emery, P. (2001) The treatment of lupus with cyclosporine A. <i>Lupus<\/i>, <b>10<\/b>, 165-170.","DOI":"10.1191\/096120301672970034"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Lebman, T.A. &amp; Onel, K. (2000) Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus. <i>J. Pediatr<\/i>., <b>136<\/b>, 243-247.","DOI":"10.1016\/S0022-3476(00)70109-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Lee, Y.M., Fujiwara, J., Munakata, Y., Ishii, T., Sugawara, A., Kaku, M., Kokubun, S., Sasaki, T. &amp; Funato, T. (2004) A mutation of the glucocorticoid receptor gene in patients with systemic lupus erythematosus. <i>Tohoku J. Exp. Med<\/i>., <b>203<\/b>, 69-76.","DOI":"10.1620\/tjem.203.69"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Nakahata, T., Tanaka, H., Tsugawa, K., Kudo, M., Suzuki, K., Ito, E. &amp; Waga, S. (2005) C<sub>1<\/sub>-C<sub>2<\/sub> point monitoring of low-dose cyclosporine A given as a single daily dose in children with steroid-dependent relapsing nephritic syndrome. <i>Clin. Nephrol<\/i>., <b>64<\/b>, 258-263.","DOI":"10.5414\/CNP64258"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Sakano, T., Ohta, T., Kinoshita, Y., Fujiwara, M. &amp; Wakai, M. (2004) Treatment of steroid-resistant systemic lupus erythematosus with extremely low dose of cyclosporine A. <i>Pediatr. Int<\/i>., <b>46<\/b>, 468-470.","DOI":"10.1111\/j.1442-200x.2004.01918.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Tanaka, H., Tateyama, T. &amp; Waga, S. (2001) Methylprednisolone pulse therapy in Japanese children with severe lupus nephritis. <i>Pediatr. Nephrol<\/i>., <b>16<\/b>, 817-819.","DOI":"10.1007\/s004670100640"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Tanaka, H., Suzuki, K., Nakahata, T., Tsugawa, K., Ito, E. &amp; Waga, S. (2003) Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis. <i>Clin. Nephrol<\/i>., <b>60<\/b>, 390-394.","DOI":"10.5414\/CNP60390"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Uchida, K., Tominaga, Y., Haba, T., Katayama, A., Matsuoka, S., Goto, N., Ueki, T., Kimata, T., Takeda, A., Morozumi, K., Takagi, H. &amp; Nakao, A. (2004) Clinical success of Neoral absorption profile. <i>Transplant Proc<\/i>., <b>36<\/b>, 461-464.","DOI":"10.1016\/j.transproceed.2004.01.090"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/208\/4\/208_4_355\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T04:02:42Z","timestamp":1497672162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/208\/4\/208_4_355\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.208.355","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006]]}}}